Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis

NCT05882812 is registered in ClinicalTrials.gov with ZetrOZ, Inc. as lead sponsor.

NCT NCT05882812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05882812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Lead sponsor
ZetrOZ, Inc.
Phase
Phase 2
Overall status
Completed
Start date
June 3, 2023
Completion date
February 22, 2024
Enrollment
200 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, osteo arthritis knee